198 related articles for article (PubMed ID: 6314363)
21. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
Rawls WE; Adam E; Melnick JL
Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
[No Abstract] [Full Text] [Related]
22. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)].
Fan J; Zeng Y; Liu YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb; 4(1):50-2. PubMed ID: 6279319
[No Abstract] [Full Text] [Related]
23. Role of HSV antibodies in precancerous & cancerous lesions of the uterine cervix--a prospective study.
Sharma BK; Gupta MM; Murthy NS; Seth P; Parashari A; Luthra UK
Indian J Med Res; 1987 Mar; 85():282-8. PubMed ID: 3038743
[No Abstract] [Full Text] [Related]
24. Herpes simplex virus type 2 and carcinoma of cervix uteri.
Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
[No Abstract] [Full Text] [Related]
25. [Type 2 Herpes simplex virus and cervical carcinoma].
Petersen EE; Böcker JF; Wimhöfer G
Zentralbl Bakteriol Orig A; 1974; 227(1-4):356-61. PubMed ID: 4154611
[No Abstract] [Full Text] [Related]
26. Relation of type 2 Herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971.
Ory H; Conger B; Richart R; Barron B
Obstet Gynecol; 1974 Jun; 43(6):901-4. PubMed ID: 4364212
[No Abstract] [Full Text] [Related]
27. Sexually transmitted infections and cervical atypia.
Schachter J
Sex Transm Dis; 1981; 8(4 suppl):353-6. PubMed ID: 6277023
[TBL] [Abstract][Full Text] [Related]
28. [Humoral immunity to herpes simplex virus type 2 in cervical cancer].
Posevaia TA; Barinskiĭ IF; Grigor'ev VV; Shuvaeva NI
Vopr Virusol; 1982; 27(3):328-30. PubMed ID: 6289530
[TBL] [Abstract][Full Text] [Related]
29. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
30. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
Kawana T; Yoshino K; Kasamatsu T
Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
[No Abstract] [Full Text] [Related]
31. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
Suárez M; Del Campo G; Ojeda JM
Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
[No Abstract] [Full Text] [Related]
32. Antibodies to herpes simplex virus (types 1 and 2) in Jamaican patients with cervical dysplasia and neoplasia.
Prabhakar P; Rao BN; Hosang R; Narla VR; Persaud V
West Indian Med J; 1984 Jun; 33(2):63-7. PubMed ID: 6091343
[No Abstract] [Full Text] [Related]
33. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
[No Abstract] [Full Text] [Related]
34. Nucleic acid hybridization and the relationship between cervical cancer and herpes simplex virus type 2.
Goodheart CR
Cancer Res; 1973 Jun; 33(6):1548-51. PubMed ID: 4352394
[No Abstract] [Full Text] [Related]
35. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
McDonald AD; Williams MC; Manfreda J; West R
Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
[No Abstract] [Full Text] [Related]
36. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
Gilman SC; Docherty JJ; Clarke A; Rawls WE
Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
[TBL] [Abstract][Full Text] [Related]
37. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
Mendis LN; Best JM; Banatvala JE
Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
[No Abstract] [Full Text] [Related]
38. Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.
Skinner GR; Whitney JE; Hartley C
Arch Virol; 1977; 54(3):211-21. PubMed ID: 196578
[TBL] [Abstract][Full Text] [Related]
39. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
[No Abstract] [Full Text] [Related]
40. Herpes simplex virus and human cancer. III. Search for relationship of herpes simplex antibodies and cervical dysplasia and labial neoplasia.
Rotola A; Gerna G; Di Luca D; Virgili AR; Manservigi R; Cassai E
Tumori; 1983 Apr; 69(2):83-7. PubMed ID: 6304957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
